MAPS is one team that's absolutely fascinated. It's got invested almost 30 decades and earmarked practically $20 million to work towards its target of creating MDMA an FDA-authorised prescription drug by 2021. If it reaches that objective, Medical doctors and scientists will have to jump by much less hoops to get their hands on MDMA for trials, or